Company & Sponsor Intelligence
University of Saskatchewan
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials3
Recruiting1
Completed2
Countries1
Therapeutic footprint
alzheimersmultiple_sclerosisstroke
Indexed studies
NCT03039400Physiotherapist-guided Home Exercise in Moderate to Severe MS
multiple_sclerosis · CanadaNA
multiple_sclerosis · CanadaNA
NCT07178678Evaluation of the Safety and Efficacy of NeuroEPO in Subjects With Mild to Moderate Alzheimer's Disease
alzheimers · CanadaPHASE2
alzheimers · CanadaPHASE2
NCT02948725Clinical Application of Cross-education During Stroke Rehabilitation
stroke · CanadaNA
stroke · CanadaNA
Intelligence layer updated: 2026-11-04 06:12:09.749896+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →